Here’s what you should know:
1. The ASA, American Hospital Association, American Society of Clinical Oncology, American Society of Health-System Pharmacists and Institute for Safe Medication Practices released a set of proposals for regulatory, legislative and marketplace solutions to drug shortages.
2. The coalition calls on the FDA to share information on potential supply chain impacts to help healthcare organizations and manufacturers prepare for possible shortages.
3. The recommendations also include commissioning a Government Accountability Office study, creating a list of critical drugs and offering incentives to manufacturers that develop contingency production plans.
4. Healthcare leaders developed the recommendations at a summit about treating drug shortages as a matter of national security.
View the recommendations here.
More articles on anesthesia:
Spinal-cord stimulators rank 3rd in injury reports to FDA over past decade
Anesthesiologists need a social media presence — Here’s why
MiraMed Global Services launches charitable campaign — 3 insights
